SurModics to Webcast First Quarter 2013 Earnings Conference Call on January 30

Wed, 01/23/2013 - 4:01pm
The Associated Press

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan 23, 2013--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its first quarter 2013 conference call on Wednesday, January 30, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, chief executive officer, and Tim Arens, vice president of finance and interim chief financial officer, will recap the first quarter 2013 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7:00 p.m. CT on Wednesday, January 30, until 7:00 p.m. CT on Wednesday, February 6 and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4593304. In addition, the conference call audio will be archived on the Company’s website following the call.

About SurModics, Inc. SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

CONTACT: SurModics, Inc.

Tim Arens, 952-500-7000 Vice President of Finance and Interim Chief Financial Officer KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES OTHER HEALTH MEDICAL SUPPLIES GENERAL HEALTH SOURCE: SurModics, Inc. Copyright Business Wire 2013 PUB: 01/23/2013 04:01 PM/DISC: 01/23/2013 04:01 PM


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.